Baumann H, Eldredge D
J Cell Biol. 1982; 95(1):29-40.
PMID: 7142289
PMC: 2112371.
DOI: 10.1083/jcb.95.1.29.
Iwata M, Nakano E
Biochem J. 1983; 215(1):205-8.
PMID: 6626176
PMC: 1152382.
DOI: 10.1042/bj2150205.
Pierschbacher M, Hayman E, Ruoslahti E
Proc Natl Acad Sci U S A. 1983; 80(5):1224-7.
PMID: 6572380
PMC: 393567.
DOI: 10.1073/pnas.80.5.1224.
HORMANN H
Klin Wochenschr. 1982; 60(20):1265-77.
PMID: 6292573
DOI: 10.1007/BF01727483.
Petersen T, Thogersen H, Skorstengaard K, Sahl P, Sottrup-Jensen L, Magnusson S
Proc Natl Acad Sci U S A. 1983; 80(1):137-41.
PMID: 6218503
PMC: 393325.
DOI: 10.1073/pnas.80.1.137.
Serum spreading factor (vitronectin) is present at the cell surface and in tissues.
Hayman E, Pierschbacher M, Ohgren Y, Ruoslahti E
Proc Natl Acad Sci U S A. 1983; 80(13):4003-7.
PMID: 6191326
PMC: 394188.
DOI: 10.1073/pnas.80.13.4003.
Fibronectins: multifunctional modular glycoproteins.
Hynes R, Yamada K
J Cell Biol. 1982; 95(2 Pt 1):369-77.
PMID: 6128348
PMC: 2112946.
DOI: 10.1083/jcb.95.2.369.
Incorporation of cellular and plasma fibronectins into smooth muscle cell extracellular matrix in vitro.
Millis A, Hoyle M, Mann D, Brennan M
Proc Natl Acad Sci U S A. 1985; 82(9):2746-50.
PMID: 3887410
PMC: 397642.
DOI: 10.1073/pnas.82.9.2746.
On the origin of species of fibronectin.
Schwarzbauer J, Paul J, Hynes R
Proc Natl Acad Sci U S A. 1985; 82(5):1424-8.
PMID: 3856272
PMC: 397274.
DOI: 10.1073/pnas.82.5.1424.
Fibronectin: source of mannose in a highly purified respiratory mucin.
Bhattacharyya S, Kaufman B, Khorrami A, Enriquez J, Manna B
Inflammation. 1988; 12(5):433-46.
PMID: 3198249
DOI: 10.1007/BF00919437.
Monoclonal antibodies to human glomerular antigens.
Nakamura T, Oite T, Kazama T, Suzuki S, ORIKASA M, Arakawa M
Virchows Arch A Pathol Anat Histopathol. 1988; 412(6):573-82.
PMID: 3129868
DOI: 10.1007/BF00844293.
Autonomous functions of structural domains on human tissue-type plasminogen activator.
van Zonneveld A, Veerman H, Pannekoek H
Proc Natl Acad Sci U S A. 1986; 83(13):4670-4.
PMID: 3088564
PMC: 323803.
DOI: 10.1073/pnas.83.13.4670.
The oncofetal domain of fibronectin defined by monoclonal antibody FDC-6: its presence in fibronectins from fetal and tumor tissues and its absence in those from normal adult tissues and plasma.
Matsuura H, Hakomori S
Proc Natl Acad Sci U S A. 1985; 82(19):6517-21.
PMID: 2995969
PMC: 390748.
DOI: 10.1073/pnas.82.19.6517.
Variants of human tissue-type plasminogen activator that lack specific structural domains of the heavy chain.
Gething M, Adler B, Boose J, Gerard R, Madison E, McGookey D
EMBO J. 1988; 7(9):2731-40.
PMID: 2846282
PMC: 457063.
DOI: 10.1002/j.1460-2075.1988.tb03127.x.
Characterization of 125I-tissue plasminogen activator binding to cerebellar granule neurons.
Verrall S, Seeds N
J Cell Biol. 1989; 109(1):265-71.
PMID: 2545726
PMC: 2115477.
DOI: 10.1083/jcb.109.1.265.
Matrix-driven translocation: dependence on interaction of amino-terminal domain of fibronectin with heparin-like surface components of cells or particles.
Newman S, Frenz D, Hasegawa E, Akiyama S
Proc Natl Acad Sci U S A. 1987; 84(14):4791-5.
PMID: 2440029
PMC: 305191.
DOI: 10.1073/pnas.84.14.4791.
The alternatively spliced V region contributes to the differential incorporation of plasma and cellular fibronectins into fibrin clots.
Wilson C, Schwarzbauer J
J Cell Biol. 1992; 119(4):923-33.
PMID: 1358897
PMC: 2289702.
DOI: 10.1083/jcb.119.4.923.
